Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ingmar, Wolffram"'
Autor:
Olaf Bätz, David Petroff, Katrin Jedrysiak, Ingmar Wolffram, Thomas Berg, Jan Kramer, Johannes Wiegand
Publikováno v:
JHEP Reports, Vol 6, Iss 9, Pp 101122- (2024)
Background & Aims: A goal of the World Health Organization’s global hepatitis strategy is the elimination of chronic hepatitis C virus (HCV) infection by 2030. As part of its strategy, the Federal Joint Committee (Germany) decided to include hepati
Externí odkaz:
https://doaj.org/article/58af17b7917d4c709cbd098b34e0ae46
Autor:
Ingmar Wolffram
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 148:175-182
ZusammenfassungSeit dem Oktober 2021 können in Deutschland alle Versicherten ab 35 Jahren einmalig bei der Gesundheitsuntersuchung (GU) auf Hepatitis B (HBV) und C (HCV) getestet werden – unabhängig von spezifischen Risiken. Dies ist ein großer
Autor:
David Petroff, Ingmar Wolffram, Olaf Bätz, Katrin Jedrysiak, Jan Kramer, Thomas Berg, Johannes Wiegand
Publikováno v:
Liver International. 43:785-793
Screening strategies for undiagnosed infections are fundamental for hepatitis C virus (HCV) elimination. We previously investigated HCV prevalence and screening strategies in an urban primary care setting. IV drug abuse, blood transfusion before 1992
Autor:
Pamela Aidelsburger, Thomas Berg, David Petroff, Anja Neumann, Jürgen Wasem, Johannes Wiegand, Cordula Barth, Ingmar Wolffram, Janine Biermann, Alexandra Grünbauer, Silke Neusser
Publikováno v:
Scandinavian Journal of Gastroenterology. 53:76-82
Systematic screening for chronic hepatitis B and C does not yet exist in Germany. Therefore, the implementation of a screening approach within a preventive medical examination performed by primary care physicians ('Check-Up 35+') was evaluated in a r
Publikováno v:
Journal of viral hepatitisREFERENCES. 26(12)
The World Health Organization and the German government have announced an initiative to eliminate chronic hepatitis C until the year 2030. To reach this goal, one important step is adequate screening and detection of so far undiagnosed infections. Th
Autor:
Ingmar, Wolffram, David, Petroff, Olaf, Bätz, Katrin, Jedrysiak, Jan, Kramer, Hannelore, Tenckhoff, Thomas, Berg, Johannes, Wiegand, T, Kottmann
Publikováno v:
Journal of Hepatology. 62:1256-1264
Background & Aims Prevalence data for hepatitis B and C and an evaluation of a guideline based screening in the primary care setting are not yet available. We therefore implemented a hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (HCV
Autor:
Olaf Bätz, J. Kramer, Thomas Berg, David Petroff, Ingmar Wolffram, Katrin Jedrysiak, Johannes Wiegand
Publikováno v:
Journal of Hepatology. 66:S408-S409
Autor:
H. Tenckhoff, Katrin Jedrysiak, Thomas Berg, David Petroff, Ingmar Wolffram, J. Kramer, Olaf Bätz, Johannes Wiegand, A. Lüllau
Publikováno v:
Journal of Hepatology. 66:S490-S491
Autor:
Johannes Wiegand, Thomas Berg, H. Tenckhoff, J. Kramer, Ingmar Wolffram, Katrin Jedrysiak, Olaf Bätz
Publikováno v:
Zeitschrift für Gastroenterologie. 51
Autor:
Thomas Berg, J. Kramer, Katrin Jedrysiak, H. Tenckhoff, David Petroff, Olaf Bätz, Johannes Wiegand, Ingmar Wolffram
Publikováno v:
Journal of Hepatology. 58:S209
508 IDENTIFICATION OF HBV AND HCV INFECTIONS IN THE PRIMARY CARE SETTING: PRE-DEFINED RISK SCENARIOS ARE A BETTER SCREENING STRATEGY THAN ELEVATED ALT VALUES J. Wiegand, O. Batz, I. Wolffram, J. Kramer, K. Jedrysiak, H. Tenckhoff, T. Berg, German “